Scholarlink

<p>Many enteric bacterial pathogens deliver virulence effectors to counteract host innate immune responses, such as inflammation and cell death, and colonize the intestinal epithelium. However, host cells recognize the disruption of their innate immune signaling by bacterial effectors and induce alternative immune responses, collectively termed “effector-triggered immunity”, to clear bacterial pathogens. Here, we describe a mechanism of cell death induction via effector-triggered immunity and the bacterial countermeasures of the pathogen <i>Shigella flexneri</i>. <i>Shigella</i> delivers the OspI effector to inhibit NF-κB activation, which results in caspase-8 activation in return. Deamidation and inactivation of the E2 ubiquitin-conjugating enzyme Ubc13 by OspI results in the inactivation of cIAPs, which serves as a cue to trigger apoptosis and necroptosis. To prevent caspase-8-mediated apoptosis, <i>Shigella</i> delivers OspC1 and inhibits caspase-8 activation via its ADP-riboxanation activity, which however triggers necroptosis. Necroptosis induced as a secondary effector-triggered immunity response by OspC1 is eventually prevented by another <i>Shigella</i> effector, OspD3. The findings of this study reveal a complex multilayered bacterial strategy for circumventing host cell death induction via effector-triggered immunity.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Shigella type-III secretion system effectors counteract the induction of host inflammation and cell death

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年9月10日

查看全文
  • Hiroshi Ashida,
  • Tokuju Okano,
  • Tamako Iida,
  • Poramed Onsoi,
  • Chihiro Sasakawa,
  • Toshihiko Suzuki

摘要

Many enteric bacterial pathogens deliver virulence effectors to counteract host innate immune responses, such as inflammation and cell death, and colonize the intestinal epithelium. However, host cells recognize the disruption of their innate immune signaling by bacterial effectors and induce alternative immune responses, collectively termed “effector-triggered immunity”, to clear bacterial pathogens. Here, we describe a mechanism of cell death induction via effector-triggered immunity and the bacterial countermeasures of the pathogen Shigella flexneri. Shigella delivers the OspI effector to inhibit NF-κB activation, which results in caspase-8 activation in return. Deamidation and inactivation of the E2 ubiquitin-conjugating enzyme Ubc13 by OspI results in the inactivation of cIAPs, which serves as a cue to trigger apoptosis and necroptosis. To prevent caspase-8-mediated apoptosis, Shigella delivers OspC1 and inhibits caspase-8 activation via its ADP-riboxanation activity, which however triggers necroptosis. Necroptosis induced as a secondary effector-triggered immunity response by OspC1 is eventually prevented by another Shigella effector, OspD3. The findings of this study reveal a complex multilayered bacterial strategy for circumventing host cell death induction via effector-triggered immunity.